Immune cells listen to what stress is saying: Neuroendocrine receptors orchestrate immune function

Methods in Molecular Biology

Volumn 934, Issue , 2012, Pages 77-87

  Jones, Harlan P ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Central nervous system; Immune cells; Mechanisms; Neuroendocrine; Stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; GLUCOCORTICOID RECEPTOR; NEUROTRANSMITTER RECEPTOR;

ANIMAL; CELLULAR IMMUNITY; CHOLINERGIC SYSTEM; CYTOLOGY; HISTOLOGY; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; NERVOUS SYSTEM; PHYSIOLOGICAL STRESS; PSYCHOPHYSIOLOGY; REVIEW;

ANIMALS; CORTICOTROPIN-RELEASING HORMONE; HUMANS; IMMUNE SYSTEM; IMMUNITY, CELLULAR; NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; PSYCHONEUROIMMUNOLOGY; RECEPTORS, GLUCOCORTICOID; RECEPTORS, NEUROTRANSMITTER; STRESS, PHYSIOLOGICAL;

EID: 84868705639     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-071-7_4     Document Type: Review

References (88)

1. Steinman L (2004) Elaborate interactions between the immune and nervous systems. Nat Immunol 5:575-581
2. Dantzer R et al (1998) Cytokines and sickness behavior. Ann N Y Acad Sci 840:586-590
3. Dantzer R et al (2000) Neural and humoral pathways of communication from the immune system to the brain: parallel or convergent? Auton Neurosci 85:60-65
4. Watkins LR et al (1995) Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci 57:1101-1126
5. Hopkins SJ, Rothwell NJ (1995) Cytokines and the nervous system I. Expression and recognition. Trends Neurosci 18:83-88
6. Barnes PJ (1998) Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin Sci 94:557-572
7. Kunicka JE et al (1993) Immunosuppression by glucocorticoids: inhibition of production of multiple lymphokines by in vivo administration of dexamethasone. Cell Immunol 149:39-49
8. Elenkov IJ et al (2000) The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52:595-638
9. Nance DM, Sanders VM (2001) Autonomic innervation and regulation of the immune system (1987-2007). Pharmacol Rev 53:487-525
10. Horin T et al (1995) The autonomic nervous system as a communication channel between the brain and the immune system. Neuroimmunomodulation 2:203-215
11. Hadden JW et al (1970) Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol 1:583-595
12. Felten DL, Felten SY (1988) Sympathetic noradrenergic innervation of immune organs. Brain Behav Immun 2:293-300
13. Elenkov IJ, Wilder RL, Chrousos GP, Vizi ES (2000) The sympathetic nerve-an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev 52: 595-638
14. Westerloo DJ (2010) The vagal immune reflex: a blessing from above. Wien Med Wochenschr 160:112-117
15. Steinman L et al (2003) The intricate interplay among body weight, stress, and the immune response to friend or foe. J Clin Invest 111:183-185
16. Wilder RL et al (1982) Strain and sex variation in the susceptibility to streptococcal cell wallinduced polyarthritis in the rat. Arthritis Rheum 25:1064-1072
17. Rozlog LA et al (1999) Stress and immunity: implications of viral disease and wound healing. J Periodontol 70:786-792
18. Glaser R, Liecolt-Glaser JK (1998) Stressassociated immune modulation: relevance to viral infections and chronic fatique syndrome. Am J Med 105:35S-42S
19. Argon A, Stanisz AM (1992) Are lymphocytes a target for substance P modulation in arthritis? Semin Arthritis Rheum 21:252-258
20. Webster EL et al (1990) Corticotropin-releasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages. Endocrinology 27:440-452
21. Nance DM, Sanders VM (2007) Autonomic innervation and regulation of the immune system. Pharmacol Rev 53:487-525
22. Kohm AP, Sanders VM (2008) Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Acta Biophys Sin (Shanghai) 40:595-600
23. Tompson EB (2008) Stepping stones in the path of glucocorticoid-driven apoptosis of lymphoid cells. Steroids 73:1025-1029
24. Elmquist JK, Scammell TE, Saper CB (1997) Mechanisms of CNS response to systemic immune challenge: the febrile response. Trends Neurosci 20:565-570
25. Mulla A, Buckingham JC (1999) Regulation of the hypothalamo-pituitary- adrenal axis by cytokines. Baillieres Best Pract Res Clin Endocrinol Metab 13:503-521
26. Dharbhar FS, McEwen BS, Spencer RL (1993) Stress response, adrenal steroid receptor levels and corticosteroid-binding globulin levels-a comparison between Spraque-Dawley, Fischer 344 and Lewis rats. Brain Res 616:89-98
27. Smith CC et al (1994) Differential mineral corticoid (type 1) and glucocorticoid (type 2) receptor expression in Lewis and Fischer rats. Neuroimmunomodulation 1:66-73
28. McKay L, Cidlowshki JA (1999) Molecular control of immune/inflammatory responses: interactions between nuclear factor-kB and steroid receptor-signaling pathways. Endocr Rev 20:435-459
29. Van der Burg B et al (1997) Nuclear factor-k B repression in antiinflammation an immunosuppression by glucocorticoids. Trends Endocrinol Metab 8:152-157
30. Brogan IJ et al (1999) Interaction of glucocorticoid receptor isoforms with transcription factors AP-1 and NF-kB: lack of effect of glucocorticoid receptor B. Mol Cell Endocrinol 157:95-104
31. Pearce D, Yamamoto K (1993) Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259:1161-1165
32. Plaut M (1987) Lymphocyte hormone receptors. Annu Rev Immunol 5:621-669
33. Pitzalis C, Piitone N, Perretti M (2002) Regulation of leukocyte-endothelial interactions by glucocorticoids. Ann N Y Acad Sci 966:108-118
34. Tamada K et al (1998) IL-4-producing NK1.1+ T cells are resistance to glucocorticoid-induced apoptosis: implications for the Th1/Th2 balance. J Immunol 161:1239-1247
35. Planey S, Litwack G (2000) Glucocorticoidinduced apoptosis in lymphocyte. Biochem Biophys Res Commun 279:307-312
36. Alamai WY, Melemedjian OK (2002) Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 71:9-15
37. Steer JH et al (1998) Altered leucocytes trafficking and suppressed tumour necrosis factor a release from peripheral blood monocytes after intraarticular glucocorticoid treatment. Ann Rheum Dis 57:732-737
38. Wingett D, Forcier K, Nielson CP (1996) Glucocorticoid mediated inhibition of RANTES expression in human T lymphocytes. FEBS Lett 398:308-311
39. Barnes PJ (2010) Mechanisms and resistance in glucocorticoid control of inflammation. J Steroid Biochem Mol Biol 120:76-85
40. Liberman AC et al (2007) Glucocorticoids in the regulation of transcription factors that control cytokine synthesis. Cytokine Growth Factor Rev 18:45-56
41. Russo-Marie F (1992) Macrophages and the glucocorticoids. J Neuroimmunol 40:281-286
42. Tait AS, Butts CL, Sternberg EM (2008) The role of glucocorticoids and progestins in inflammatory, autoimmune, and infectious disease. J Leukoc Biol 84:924-931
43. Schif-Zuck S et al (2011) Saturated-efferocytosis generates proresolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol 41:336-379
44. Goulding NK et al (1998) Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation. In flamm Res 47:S158-S165
45. Strausbaugh HJ, Rosen SD (1998) A potential role for annexin 1 as a physiologic mediator of glucocorticoid-induced L-selectin shedding from myeloid cells. J Immunol 166:294-300
46. Kontula K et al (1983) Binding of progestins to the glucocorticoid receptor. Correlation to their glucocorticoid-like effects on in vitro functions of human mononuclear leukocytes. Biochem Pharmacol 32:1511-1518
47. McColl A et al (2007) Effects of glucocorticoids on apoptosis and clearance of apoptotic cells. ScientificWorldJournal 17:1165-1181
48. Ashwell JD, Lu FWM, Ms V (2000) Glucocorticoids in T cell development and function. Annu Rev Immunol 18:309-345
49. Zen M et al (2011) The kaleidoscope of glucocorticoid effects on immune system. Autoimmun Rev 10:305-310
50. Moser M et al (1995) Glucocorticoids downregulate dendritic cell function in vitro and in vivo. Eur J Immunol 10:2818-2824
51. Roca L et al (2007) Dexamethasone modulates interleukin-12 production by inducing monocyte chemoattractant protein-1 in human dendritic cells. Immunol Cell Biol 8:610-616
52. Vacchio MS, Lee JJ, Ashwell JD (1999) Thymus-derived glucocorticoids set the thresholds for thymocyte selection by inhibiting TCR-mediated thymocyte activation. J Immunol 163:1327-1333
53. Palinkas L et al (2008) Developmental shift in TcR-mediated rescue of thymocytes from glucocorticoid-induced apoptosis. Immunobiology 213:39-50
54. Purton JF et al (2004) Expression of the glucocorticoid receptor from the 1A promoter correlates with T lymphocyte sensitivity to glucocorticoid-induced cell death. J Immunol 173:3816-3824
55. Takeda T et al (2008) Crosstalk between the interleukin-6 (IL-6)-JAK-STAT and the glucocorticoid-nuclear receptor pathway: synergistic activation of IL-6 response element by IL-6 and glucocorticoid. J Endocrinol 159: 323-330
56. Adcock IM (2001) Glucocorticoid-regulated transcription factors. Pulm Pharmacol Ther 14:211-219
57. Van Oosten MJ et al (2010) Polymorphisms n the glucocorticoid receptor gene that modulate glucocorticoid sensitivity are associated with rheumatoid arthritis. Arthritis Res Ther 12:R159
58. Vazquez-Tello A et al (2010) Induction of glucocorticoid receptor-beta expression in epithelial cells of asthmatic airways by T-helper type 17 cytokines. Clin Exp Allergy 40(9):1312-1322
59. Belinger DL et al (2008) Sympathetic modulation of immunity: relevance to disease. Cell Immunol 2:27-56
60. Nance DM, Sanders VM (2007) Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 21: 736-745
61. Madden KS, Sanders VM, Felten DL (1995) Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 35:417-448
62. Logan RW, Ariona A, Sarkar DK (2011) Role of sympathetic nervous system in the entrainment of circadian natural-killer cell function. Brain Behav Immun 25:101-109
63. Woods JA (2000) Exercised and neuroendocrine modulation of macrophage function. Int J Sports Med 21:S24-S30
64. Maestroni GJ (2006) Sympathetic nervous system influence on the innate immune response. Ann N Y Acad Sci 1069:195-207
65. Shahabi S et al (2006) Sympathetic nervous system plays an important role in the relationship between immune mediated diseases. Med Hypotheses 67:900-903
66. Sanders VM et al (1997) Differential expression of the beta-2-adrenergic receptor by Th1 and Th2 clones: implications for cytokine production and B cell help. J Immunol 158:4200-4210
67. Panine-Bordignon P et al (1997) Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 100:1513-1519
68. Kim BJ, Jones HP (2010) Epinephrine-primed murine bone marrow-derived dendritic cells facilitate production of IL-17A and IL-4 but not IFN-g by CD4+ T cells. Brain Behav Immun 24:1126-1136
69. Borovikova LV et al (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405:458-462
70. Sato KZ et al (1999) Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett 266:17-20
71. Borovikova LV et al (2000) Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton Neurosci 85:141-147
72. Yoshikawa H et al (2006) Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kappaB phosphorylation and nuclear factor-kappaB transcriptional activity through nicotinic acetylcholine receptor alpha7. Clin Exp Immunol 146:116-123
73. de Jonge WJ, van der Zanden EP (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6:844-851
74. Vale W et al (1981) Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and betaendorphin. Science 213:1394-1397
75. Chen R et al (1993) Expression cloning of a human corticotropin- releasing-factor receptor. Proc Natl Acad Sci U S A 90:8967-8971
76. Kalantaridou S et al (2007) Peripheral corticotropin-releasing hormone is produced in the immune and reproductive systems: actions, potential roles and clinical implications. Front Biosci 12:572-580
77. Tache Y, Kiank C, Stengel A (2009) A role for corticotropin-releasing factor in functional gastrointestinal disorders. Curr Gastroenterol Rep 11:270-277
78. Slominski A et al (2001) Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J 15:1678-1693
79. Gonzales XF et al (2008) Stress-induced differences in primary and secondary resistance against bacterial sepsis corresponds with diverse corticotropin releasing hormone receptor expression by pulmonary CD11c+ MHC II+ and CD11c-MHC II+ APCs. Brain Behav Immun 22:552-564
80. Cao J et al (2005) Human mast cells express corticotropin-releasing hormone (CRH) receptors and CRH leads to selective secretion of vascular endothelial growth factor. J Immunol 174:7665-7675
81. Webster EL et al (1990) Corticotropinreleasing factor receptors in mouse spleen: identification of receptor-bearing cells as resident macrophages. Endocrinology 127: 440-452
82. Agelaki S et al (2002) Corticotropin-releasing hormone augments proinflammatory cytokine production from macrophages in vitro and in lipopolysaccharide-induced endotoxin shock in mice. Infect Immun 70:6068-6074
83. Wallon C, Soderholm JD (2009) Corticotropinreleasing hormone and mast cells in the regulation of mucosal barrier function in the human colon. Ann N Y Acad Sci 1165:206-210
84. Gao L et al (2007) Corticotropin-releasing hormone receptor type 1 and type 2 mediate differential effects on 15-hydroxy prostaglandin dehydrogenase expression in cultured human chorion trophoblasts. Endocrinology 148:3645-3654
85. Kokkotou E et al (2006) Corticotropinreleasing hormone receptor 2-deficient mice have reduced intestinal in flammatory responses. J Immunol 177:3355-3361
86. Moffatt JD, Lever R, Page CP (2006) Activation of corticotropin-releasing factor receptor-2 causes bronchorelaxation and inhibits pulmonary inflammation in mice. FASEB J 20:1877-1879
87. Watkins LR, Maier SF (2005) Immune regulation of central nervous system functions: from sickness responses to pathological pain. J Intern Med 257:139-155
88. Vedhara K et al (1999) Chronic stress in elderly carers of dementia patients and antibody response to in fluenza vaccination. Lancet 353: 627-631